<p>Omada Health（纳斯达克：OMDA - 获取免费报告）在周五向投资者发布的报告中，巴克莱的股票分析师将其目标价从 21.00 美元上调至 24.00 美元。该公司目前对该股票的评级为 “增持”。巴克莱的目标价暗示该股票当前价格有 20.60% 的潜在上涨空间。</p>
<p>其他几位分析师也最近对该公司发表了看法。高盛集团在 7 月 1 日（星期二）发布的报告中开始覆盖 Omada Health。他们为该公司设定了 “买入” 评级和 29.00 美元的目标价。摩根大通在 7 月 1 日（星期二）发布的报告中对 Omada Health 进行了覆盖。他们给予了 “增持” 评级和 19.00 美元的目标价。华尔街 Zen 在 6 月 16 日（星期一）的研究报告中将 Omada Health 的评级上调至 “持有”。Evercore ISI 在 7 月 9 日（星期三）的研究报告中将 Omada Health 的目标价从 21.00 美元上调至 23.00 美元，并给予该股票 “跑赢大盘” 的评级。最后，加拿大皇家银行在 7 月 1 日（星期二）的报告中开始覆盖 Omada Health 的股票。他们给予了 “买入” 评级和 27.00 美元的目标价。一位分析师对该股票给予了持有评级，七位分析师对该公司给予了买入评级。根据 MarketBeat 的数据，该公司的平均评级为 “适度买入”，共识目标价为 24.43 美元。</p>
<p><strong>获取我们关于 Omada Health 的最新股票报告</strong></p>
<h2>Omada Health 股票上涨 2.3%</h2>
<p>OMDA 股票在周五交易中上涨 0.44 美元，达到 19.90 美元。该公司的交易量为 196,182 股，而其平均交易量为 735,662 股。Omada Health 的 52 周低点为 14.14 美元，52 周高点为 28.40 美元。</p>
<p>Omada Health（纳斯达克：OMDA - 获取免费报告）最近于 8 月 7 日（星期四）发布了季度财报。该公司报告的季度每股收益为（0.22 美元），低于分析师共识预期的（0.15 美元），差距为（0.07 美元）。该公司在本季度的收入为 6137 万美元，而分析师预期为 5517 万美元。</p>
<h2>机构投资者对 Omada Health 的看法</h2>
<p>对冲基金和其他机构投资者最近对该股票的持仓进行了调整。德克萨斯州教师退休系统在第二季度收购了 Omada Health 的新股份，价值约为 640,000 美元。Emerald Mutual Fund Advisers Trust 在第二季度购买了 Omada Health 的新头寸，价值约为 295 万美元。Jennison Associates LLC 在第二季度购买了 Omada Health 的新头寸，价值约为 458 万美元。Emerald Advisers LLC 在第二季度收购了 Omada Health 的新头寸，价值约为 508.9 万美元。最后，赛诺菲在第二季度收购了 Omada Health 的新股份，价值为 960.6 万美元。</p>
<h2>Omada Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Omada 的使命是改变趋势。我们的希望是，有一天，明天的流行病学家会注意到疾病曲线的变化，想知道发生了什么，并得出部分影响来自 Omada 的结论。作为这一使命的一部分，我们努力激励和帮助人们以自己的方式进行持久的健康改变。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Omada Health</li>
<li>技术股票解析：关于科技你需要知道的事</li>
<li>为什么 Axon 的 16% 激增标志着公共安全科技的新纪元</li>
<li>什么样的股票是好的分红股票？</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>什么是稀释每股收益（Diluted EPS）？</li>
<li>亚马逊在 IonQ 中获得股权——有什么上涨潜力？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Omada Health 吗？</h2>
<p>在你考虑 Omada Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Omada Health 并不在名单上。</p>
<p>虽然 Omada Health 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

OMDA

<p>巴克莱将 Omada Health（NASDAQ:OMDA）的目标股价从 21.00 美元上调至 24.00 美元，维持 “增持” 评级。这表明与当前价格相比，潜在上涨幅度为 20.60%。其他分析师也给予了积极的评级，高盛设定的目标为 29.00 美元，加拿大皇家银行的目标为 27.00 美元。Omada Health 的股价上涨了 2.3%，达到 19.90 美元，市场共识目标价为 24.43 美元。该公司报告的收入为 6137 万美元，但在最近的季度业绩中未能达到每股收益预期</p>

<p>Omada Health (NASDAQ:OMDA - Get Free Report) had its price objective raised by stock analysts at Barclays from $21.00 to $24.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an &#34;overweight&#34; rating on the stock. Barclays's target price would suggest a potential upside of 20.60% from the stock's current price.</p>
<div class="lb-trans"><p>Omada Health（纳斯达克：OMDA - 获取免费报告）在周五向投资者发布的报告中，巴克莱的股票分析师将其目标价从 21.00 美元上调至 24.00 美元。该公司目前对该股票的评级为 “增持”。巴克莱的目标价暗示该股票当前价格有 20.60% 的潜在上涨空间。</p>
</div><p>Several other analysts have also recently weighed in on the company. The Goldman Sachs Group began coverage on Omada Health in a report on Tuesday, July 1st. They set a &#34;buy&#34; rating and a $29.00 price objective for the company. JPMorgan Chase &amp; Co. initiated coverage on Omada Health in a report on Tuesday, July 1st. They issued an &#34;overweight&#34; rating and a $19.00 price objective for the company. Wall Street Zen upgraded Omada Health to a &#34;hold&#34; rating in a research report on Monday, June 16th. Evercore ISI lifted their price objective on shares of Omada Health from $21.00 to $23.00 and gave the stock an &#34;outperform&#34; rating in a research note on Wednesday, July 9th. Finally, Canaccord Genuity Group assumed coverage on shares of Omada Health in a report on Tuesday, July 1st. They issued a &#34;buy&#34; rating and a $27.00 price target for the company. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $24.43.</p>
<div class="lb-trans"><p>其他几位分析师也最近对该公司发表了看法。高盛集团在 7 月 1 日（星期二）发布的报告中开始覆盖 Omada Health。他们为该公司设定了 “买入” 评级和 29.00 美元的目标价。摩根大通在 7 月 1 日（星期二）发布的报告中对 Omada Health 进行了覆盖。他们给予了 “增持” 评级和 19.00 美元的目标价。华尔街 Zen 在 6 月 16 日（星期一）的研究报告中将 Omada Health 的评级上调至 “持有”。Evercore ISI 在 7 月 9 日（星期三）的研究报告中将 Omada Health 的目标价从 21.00 美元上调至 23.00 美元，并给予该股票 “跑赢大盘” 的评级。最后，加拿大皇家银行在 7 月 1 日（星期二）的报告中开始覆盖 Omada Health 的股票。他们给予了 “买入” 评级和 27.00 美元的目标价。一位分析师对该股票给予了持有评级，七位分析师对该公司给予了买入评级。根据 MarketBeat 的数据，该公司的平均评级为 “适度买入”，共识目标价为 24.43 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Omada Health</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Omada Health 的最新股票报告</strong></p>
</div><h2>Omada Health Stock Up 2.3%</h2>
<div class="lb-trans"><h2>Omada Health 股票上涨 2.3%</h2>
</div><p>OMDA stock traded up $0.44 during trading on Friday, hitting $19.90. The company had a trading volume of 196,182 shares, compared to its average volume of 735,662. Omada Health has a fifty-two week low of $14.14 and a fifty-two week high of $28.40.</p>
<div class="lb-trans"><p>OMDA 股票在周五交易中上涨 0.44 美元，达到 19.90 美元。该公司的交易量为 196,182 股，而其平均交易量为 735,662 股。Omada Health 的 52 周低点为 14.14 美元，52 周高点为 28.40 美元。</p>
</div><p>Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.07). The company had revenue of $61.37 million during the quarter, compared to analyst estimates of $55.17 million.</p>
<div class="lb-trans"><p>Omada Health（纳斯达克：OMDA - 获取免费报告）最近于 8 月 7 日（星期四）发布了季度财报。该公司报告的季度每股收益为（0.22 美元），低于分析师共识预期的（0.15 美元），差距为（0.07 美元）。该公司在本季度的收入为 6137 万美元，而分析师预期为 5517 万美元。</p>
</div><h2>Institutional Investors Weigh In On Omada Health</h2>
<div class="lb-trans"><h2>机构投资者对 Omada Health 的看法</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the stock. Teacher Retirement System of Texas acquired a new stake in shares of Omada Health in the second quarter valued at about $640,000. Emerald Mutual Fund Advisers Trust bought a new position in Omada Health during the 2nd quarter worth approximately $2,950,000. Jennison Associates LLC bought a new position in Omada Health during the 2nd quarter worth approximately $4,580,000. Emerald Advisers LLC acquired a new position in shares of Omada Health in the 2nd quarter worth approximately $5,089,000. Finally, Sanofi bought a new stake in shares of Omada Health in the 2nd quarter valued at $9,606,000.</p>
<div class="lb-trans"><p>对冲基金和其他机构投资者最近对该股票的持仓进行了调整。德克萨斯州教师退休系统在第二季度收购了 Omada Health 的新股份，价值约为 640,000 美元。Emerald Mutual Fund Advisers Trust 在第二季度购买了 Omada Health 的新头寸，价值约为 295 万美元。Jennison Associates LLC 在第二季度购买了 Omada Health 的新头寸，价值约为 458 万美元。Emerald Advisers LLC 在第二季度收购了 Omada Health 的新头寸，价值约为 508.9 万美元。最后，赛诺菲在第二季度收购了 Omada Health 的新股份，价值为 960.6 万美元。</p>
</div><h2>Omada Health Company Profile</h2>
<div class="lb-trans"><h2>Omada Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.</p>
<div class="lb-trans"><p>Omada 的使命是改变趋势。我们的希望是，有一天，明天的流行病学家会注意到疾病曲线的变化，想知道发生了什么，并得出部分影响来自 Omada 的结论。作为这一使命的一部分，我们努力激励和帮助人们以自己的方式进行持久的健康改变。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Omada Health</li>
<li>Technology Stocks Explained: Here's What to Know About Tech</li>
<li>Why Axon's 16% Surge Signals a New Era in Public Safety Tech</li>
<li>What Makes a Stock a Good Dividend Stock?</li>
<li>DraftKings Posts Record Quarter, Eyes Profitability</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>Amazon Takes an Equity Stake in IonQ—Any Upside Potential?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Omada Health</li>
<li>技术股票解析：关于科技你需要知道的事</li>
<li>为什么 Axon 的 16% 激增标志着公共安全科技的新纪元</li>
<li>什么样的股票是好的分红股票？</li>
<li>DraftKings 发布创纪录季度，瞄准盈利</li>
<li>什么是稀释每股收益（Diluted EPS）？</li>
<li>亚马逊在 IonQ 中获得股权——有什么上涨潜力？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T01EQQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=OMDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Omada Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Omada Health 吗？</h2>
</div><p>Before you consider Omada Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Omada Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Omada Health 并不在名单上。</p>
</div><p>While Omada Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Omada Health 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Omada Health（纳斯达克股票代码：OMDA）在巴克莱的目标股价被上调至 24.00 美元